Multivalue ethical framework for fair global allocation of a COVID-19 vaccine.
J Med Ethics
; 46(8): 499-501, 2020 08.
Article
in English
| MEDLINE | ID: covidwho-597630
ABSTRACT
The urgent drive for vaccine development in the midst of the current COVID-19 pandemic has prompted public and private organisations to invest heavily in research and development of a COVID-19 vaccine. Organisations globally have affirmed the commitment of fair global access, but the means by which a successful vaccine can be mass produced and equitably distributed remains notably unanswered. Barriers for low-income countries include the inability to afford vaccines as well as inadequate resources to vaccinate, barriers that are exacerbated during a pandemic. Fair distribution of a pandemic vaccine is unlikely without a solid ethical framework for allocation. This piece analyses four allocation paradigms ability to develop or purchase; reciprocity; ability to implement; and distributive justice, and synthesises their ethical considerations to develop an allocation model to fit the COVID-19 pandemic.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Social Justice
/
Viral Vaccines
/
Health Care Rationing
/
Global Health
/
Coronavirus Infections
/
Health Equity
/
Pandemics
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
J Med Ethics
Year:
2020
Document Type:
Article
Affiliation country:
Medethics-2020-106516
Similar
MEDLINE
...
LILACS
LIS